Sponsor Pipeline

Edgewise Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
0
Recruiting
1
Disease Areas
8
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07177066
A Study of EDG-15400 in Healthy Adults
Trial completed
2026-08-06 NCT07177066
A Study of EDG-15400 in Healthy Adults
Enrollment reduced: 108 -> 84 participants
2026-08-01 NCT06347159
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
Enrollment reduced: 100 -> 79 participants
2026-08-01 NCT06347159
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
date change Primary completion pushed: 2026-06 -> 2027-12
2026-08-01 NCT06347159
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
date change Completion pushed: 2026-12 -> 2027-12
2026-08-01 NCT07456059
A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults
Completed without a posted recruiting period
2026-08-01 NCT07324616
A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment
Trial completed
2026-08-01 NCT07324616
A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment
Enrollment reduced: 32 -> 25 participants
Active Trials by Phase
Phase 2
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06100887 Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy… Duchenne Muscular Dystrophy Active, Not Recruiting
NCT05540860 A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX) Duchenne Muscular Dystrophy Active, Not Recruiting
NCT05291091 Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) Becker Muscular Dystrophy Active, Not Recruiting
NCT06066580 Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy Becker Muscular Dystrophy Enrolling by Invitation
NCT06347159 A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM) Hypertrophic Cardiomyopathy Active, Not Recruiting
Disease Areas
Get alerts when Edgewise Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free